624 research outputs found
Correction to: Sol–Gel Synthesis of High-Density Zeolitic Imidazolate Framework Monoliths via Ligand Assisted Methods: Exceptional Porosity, Hydrophobicity, and Applications in Vapor Adsorption (Advanced Functional Materials, (2021), 31, 5, (2008357), 10.1002/adfm.202008357)
In the original published version of this article, the bulk densities of the powder ZIF-8 and ZIF-67 were quoted as 0.96 g/cm3 and 0.94 g/cm3 respectively. However, the values for the powder samples’ true density were quoted in error. The correct bulk densities, used for calculating volume-relative capacities and surface areas, were 0.39 g/cm3 and 0.38 g/cm3 for ZIF-8 and ZIF-67, respectively. As this affects the calculated ‘volume-relative’ quantities, corrected tables and graphs are included below. The authors apologise for any inconvenience or confusion this error may have caused. Corrected tables Corrected values will be written and underlined in red. 1 Table Physical characteristics of ZIF samples. Surface areas and porosities expressed in mass-relative and volume-relative terms. Tpycometry = 25 °C. Tgas adsorption = -196 °C (Table presented.) a) Volume-relative quantities calculated by multiplying bulk density by mass-relative quantity b) Due to lack of micropores within sample, micropore volume could not be determined. 3 Table Summary of low concentration dynamic adsorption experiments. All measurements carried out at a toluene partial pressure of 0.00026, and a temperature of 25 °C (Table presented.) a) Calculated by dividing capacity when toluene is first detected by the capacity when the inlet and outlet concentrations of toluene are equal. 4 Table Estimated mass-relative and volume-relative toluene vapour capture productivities for adsorbents. Calculated using gravimetric toluene adsorption data at a partial pressure of 0.1 and a temperature of 25 °C (Table presented.) a) Time taken to reach a mass gradient value of 0.00075% dry mass per minute. Corrected main text figures 6 Figure (Figure presented.) Co-sorption volume-relative toluene vapour capacities as a function of process humidity, for zinc (left) and cobalt (right) ZIF samples. Partial pressure of toluene in all measurements, P/P0 = 0.005, while water vapour partial pressure varied. All measurements carried out at 25 °C. Corrected supplementary information figures S4 Figure (Figure presented.) Volume-relative nitrogen adsorption isotherms for zinc (left) and cobalt (right) samples. Temperature in all experiments is -196 °C. S5 Figure (Figure presented.) Volume-relative adsorption isotherms for zinc (left) and cobalt (right) samples: water (top), toluene (middle), methanol (bottom). Temperature in all experiments is 25 °C
Exploration of the Mid-Cayman Rise
Oceanography articles are licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution, and reproduction in any medium or format as long as users cite the materials appropriately (e.g., authors, Oceanography, volume number, issue number, page number[s], figure number[s], and DOI for the article), provide a link to the Creative Commons license, and indicate the changes that were made to the original content
Comparing the effectiveness of the 0.018-inch versus the 0.022-inch bracket slot system in orthodontic treatment:study protocol for a randomized controlled trial
BACKGROUND: Edgewise fixed orthodontic appliances are available in two different bracket slot sizes (0.018 and 0.022 inch). Both systems are used by clinicians worldwide with some orthodontists claiming the superiority and clinical advantages of one system over the other. However, the scientific evidence supporting this area is scarce and weak. This leaves the clinician’s choice of bracket slot system to clinical preference. We aim to compare the 0.018-inch and 0.022-inch pre-adjusted bracket slot systems in terms of the effectiveness of orthodontic treatment. METHODS/DESIGN: This is a prospective, multicenter, randomized clinical trial, undertaken in the secondary care hospital environment in the NHS Tayside region of Scotland (United Kingdom). A total of 216 orthodontic patients will be recruited in three centers in secondary care hospitals in NHS Tayside. The participants will be randomly allocated to treatment with either the 0.018-inch or 0.022-inch bracket slot systems (n = 108 for each group) using Victory series™ conventional pre-adjusted bracket systems (3 M Unitek, Monrovia, United States). Baseline records and outcome data collected during and at the end of orthodontic treatment will be assessed. The primary outcome measures will be the duration of orthodontic treatment in the maxillary and mandibular arches. The secondary outcome measures will be the number of scheduled appointments for orthodontic treatment in the maxillary and mandibular arches, treatment outcome using Peer Assessment Rating index (PAR), orthodontically induced inflammatory root resorption (as measured using periapical radiographs) and the patient’s perception of wearing orthodontic appliances. DISCUSSION: The results from the current study will serve as evidence to guide the clinician in deciding whether the difference in bracket slot size has a significant impact on the effectiveness of orthodontic treatment. TRIAL REGISTRATION: Registered with ClinicalTrials.gov on 5 March 2014, registration number: NCT02080338
Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary care
BACKGROUND: Poorly controlled hypertension is independently associated with mortality, cardiovascular risk and disease progression in chronic kidney disease (CKD). In the UK, CKD stage 3 is principally managed in primary care, including blood pressure (BP) management. Controlling BP is key to improving outcomes in CKD. This study aimed to investigate associations of BP control in people with CKD stage 3. METHODS: 1,741 patients with CKD 3 recruited from 32 general practices for the Renal Risk in Derby Study underwent medical history, clinical assessment and biochemistry testing. BP control was assessed by three standards: National Institute for Health and Clinical Excellence (NICE), National Kidney Foundation Kidney Disease Outcome Quality Initiative (KDOQI) and Kidney Disease: Improving Global Outcomes (KDIGO) guidelines. Descriptive statistics were used to compare characteristics of people achieving and not achieving BP control. Univariate and multivariate logistic regression was used to identify factors associated with BP control. RESULTS: The prevalence of hypertension was 88%. Among people with hypertension, 829/1426 (58.1%) achieved NICE BP targets, 512/1426 (35.9%) KDOQI targets and 859/1426 (60.2%) KDIGO targets. Smaller proportions of people with diabetes and/or albuminuria achieved hypertension targets. 615/1426 (43.1%) were only taking one antihypertensive agent. On multivariable analysis, BP control (NICE and KDIGO) was negatively associated with age (NICE odds ratio (OR) 0.27; 95% confidence interval (95% CI) 0.17-0.43) 70–79 compared to <60), diabetes (OR 0.32; 95% CI 0.25-0.43)), and albuminuria (OR 0.56; 95% CI 0.42-0.74)). For the KDOQI target, there was also association with males (OR 0.76; 95% CI 0.60-0.96)) but not diabetes (target not diabetes specific). Older people were less likely to achieve systolic targets (NICE target OR 0.17 (95% CI 0.09,0.32) p < 0.001) and more likely to achieve diastolic targets (OR 2.35 (95% CI 1.11,4.96) p < 0.001) for people >80 compared to < 60). CONCLUSIONS: Suboptimal BP control was common in CKD patients with hypertension in this study, particularly those at highest risk of adverse outcomes due to diabetes and or albuminuria. This study suggests there is scope for improving BP control in people with CKD by using more antihypertensive agents in combination while considering issues of adherence and potential side effects
New Measurement of Parity Violation in Elastic Electron-Proton Scattering and Implications for Strange Form Factors
We have measured the parity-violating electroweak asymmetry in the elastic
scattering of polarized electrons from the proton. The result is A = -15.05 +-
0.98(stat) +- 0.56(syst) ppm at the kinematic point theta_lab = 12.3 degrees
and Q^2 = 0.477 (GeV/c)^2. The measurement implies that the value for the
strange form factor (G_E^s + 0.392 G_M^s) = 0.025 +- 0.020 +- 0.014, where the
first error is experimental and the second arises from the uncertainties in
electromagnetic form factors. This measurement is the first fixed-target parity
violation experiment that used either a `strained' GaAs photocathode to produce
highly polarized electrons or a Compton polarimeter to continuously monitor the
electron beam polarization.Comment: 8 pages, 4 figures, Tex, elsart.cls; revised version as accepted for
Phys. Lett.
The deuteron: structure and form factors
A brief review of the history of the discovery of the deuteron in provided.
The current status of both experiment and theory for the elastic electron
scattering is then presented.Comment: 80 pages, 33 figures, submited to Advances in Nuclear Physic
Suboptimal asthma care for immigrant children: results of an audit study
<p>Abstract</p> <p>Background</p> <p>Little is known on the scope and nature of ethnic inequalities in suboptimal asthma care for children. This study aimed to assess (1) ethnic differences in suboptimal asthma care for children with an asthma exacerbation who consulted a physician, and (2) ethnic differences in the nature of suboptimal care.</p> <p>Methods</p> <p>All children aged 6–16 years who during a period of six months consulted the paediatric department of the Academic Medical Centre-University of Amsterdam or one of the six regional primary care centres with an asthma exacerbation were included. Clinical guidelines were systematically converted to review criteria following the strategy as proposed by the Agency for Health Care Policy and Research. Based upon these review criteria and their experience experts of two multidisciplinary panels retrospectively assessed the quality of care and its (possible) failure to prevent the occurrence of asthma exacerbation.</p> <p>Results</p> <p>Only a small number of children (n = 35) were included in the analysis as a result of which the ethnic differences in suboptimal care were not significant. However, the results do indicate immigrant children, in particular 'other non-Western' children (n = 11), more frequently to receive suboptimal care related to the asthma exacerbation when compared to ethnic Dutch children. Furthermore, we found the nature of suboptimal care to differ with under-prescribing in the 'other non-Western' group (n = 11), lack of information exchange between physicians in the Surinamese/Antillean group (n = 12) and lack of education, and counselling of patients and parents in the ethnic Dutch (n = 12) as the most relevant factor.</p> <p>Conclusion</p> <p>Ethnic inequalities in the scope and nature of suboptimal asthma care for children in the Netherlands seem to exist. For the non-western immigrant groups the results indicate the importance of the prescription behaviour of the medical doctor, as well as the supervision by one health care provider.</p
Oral vitamin B(12 )therapy in the primary care setting: a qualitative and quantitative study of patient perspectives
BACKGROUND: Although oral replacement with high doses of vitamin B(12 )is both effective and safe for the treatment of B(12 )deficiency, little is known about patients' views concerning the acceptability and effectiveness of oral B(12). We investigated patient perspectives on switching from injection to oral B(12 )therapy. METHODS: This study involved a quantitative arm using questionnaires and a qualitative arm using semi-structured interviews, both to assess patient views on injection and oral therapy. Patients were also offered a six-month trial of oral B(12 )therapy. One hundred and thirty-three patients who receive regular B(12 )injections were included from three family practice units (two hospital-based academic clinics and one community health centre clinic) in Toronto. RESULTS: Seventy-three percent (63/86) of respondents were willing to try oral B(12). In a multivariate analysis, patient factors associated with a "willingness to switch" to oral B(12 )included being able to get to the clinic in less than 30 minutes (OR 9.3, 95% CI 2.2–40.0), and believing that frequent visits to the health care provider (OR 5.4, 95% CI 1.1–26.6) or the increased costs to the health care system (OR 16.7, 95% CI 1.5–184.2) were disadvantages of injection B(12). Fifty-five patients attempted oral therapy and 52 patients returned the final questionnaire. Of those who tried oral therapy, 76% (39/51) were satisfied and 71% (39/55) wished to permanently switch. Factors associated with permanently switching to oral therapy included believing that the frequent visits to the health care provider (OR 35.4, 95% CI 2.9–432.7) and travel/parking costs (OR 8.7, 95% CI 1.2–65.3) were disadvantages of injection B(12). Interview participants consistently cited convenience as an advantage of oral therapy. CONCLUSION: Switching patients from injection to oral B(12 )is both feasible and acceptable to patients. Oral B(12 )supplementation is well received largely due to increased convenience. Clinicians should offer oral B(12 )therapy to their patients who are currently receiving injections, and newly diagnosed B(12)-deficient patients who can tolerate and are compliant with oral medications should be offered oral supplementation
A Common Origin for Cosmic Explosions Inferred from Fireball Calorimetry
Past studies suggest that long-duration gamma-ray bursts (GRBs) have a
standard energy of E_gamma ~ 10^51 erg in ultra-relativistic ejecta when
corrected for asymmetry ("jets"). However, recently a group of sub-energetic
bursts, including the peculiar GRB 980425 associated with SN 1998bw (E_gamma ~
10^48 erg), has been identified. Here we report radio observations of GRB
030329, the nearest burst to date, which allow us to undertake calorimetry of
the explosion. Our observations require a two-component explosion: a narrow (5
degrees) ultra-relativistic component responsible for the gamma-rays and early
afterglow, and a wide, mildly relativistic component responsible for the radio
and optical afterglow beyond 1.5 days. While the gamma-rays are energetically
minor, the total energy release, dominated by the wide component, is similar to
that of other GRBs. Given the firm link of GRB 030329 with SN 2003dh our result
suggests a common origin for cosmic explosions in which, for reasons not
understood, the energy in the highest velocity ejecta is highly variableComment: Accepted to Natur
Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice
<p>Abstract</p> <p>Background</p> <p>Histone deacetylase (HDAC) inhibitors, developed as promising anti-tumor drugs, exhibit their anti-inflammatory properties due to their effects on reduction of inflammatory cytokines.</p> <p>Objective</p> <p>To investigate the protective effect of butyrate, a HDAC inhibitor, on lipopolysaccharide (LPS)-induced acute lung injury (ALI) in mice.</p> <p>Methods</p> <p>ALI was induced in Balb/c mice by intratracheally instillation of LPS (1 mg/kg). Before 1 hour of LPS administration, the mice received butyrate (10 mg/kg) orally. The animals in each group were sacrificed at different time point after LPS administration. Pulmonary histological changes were evaluated by hematoxylin-eosin stain and lung wet/dry weight ratios were observed. Concentrations of interleukin (IL)-1β and tumor necrosis factor (TNF)-α in bronchoalveolar lavage fluid (BALF) and concentrations of nitric oxide (NO) and myeloperoxidase (MPO) activity in lung tissue homogenates were measured by enzyme-linked immunosorbent assay (ELISA). Expression of nuclear factor (NF)-κB p65 in cytoplasm and nucleus was determined by Western blot analysis respectively.</p> <p>Results</p> <p>Pretreatment with butyrate led to significant attenuation of LPS induced evident lung histopathological changes, alveolar hemorrhage, and neutrophils infiltration with evidence of reduced MPO activity. The lung wet/dry weight ratios, as an index of lung edema, were reduced by butyrate administration. Butyrate also repressed the production of TNF-α, IL-1β and NO. Furthermore, the expression of NF-κB p65 in nucleus was markedly suppressed by butyrate pretreatment.</p> <p>Conclusions</p> <p>Butyrate had a protective effect on LPS-induced ALI, which may be related to its effect on suppression of inflammatory cytokines production and NF-κB activation.</p
- …